Clinical Diagnostics Are Increasingly Precise - Get the Most Accurate Results Possible

You need accurate and consistent results.

But your reagents are not doing their job!

Get a new stabilizer and blocking agent that works as hard as you do for the best results.

Clinical diagnostics rely on sensitive molecular diagnostic techniques including antibody testing or an immunoassay plus real-time PCR. Precision and consistency of results is vital in applications like:

• 1. Obtaining an accurate diagnosis
• 2. Monitoring a patient's response to therapy
• 3. Detecting small changes in a hormone or biomarker

With any common diagnostic immunoassay, these problems may arise:

• Lack of specificity
• Difficulty stabilizing a sensitive biomarker or protein
• Cross reactivity and non-specific binding
• An ineffective coating agent
• Inconsistent or inaccurate results

The Real Problem

The main problem is the quality of the diagnostic stabilizer reagents used. Performance failure and inaccurate results usually result from:

• Perishable reagents
• Lack of chemical reagent consistency
• Defective components
• Poorly designed assay kits

Additional challenges arise as a result of the use of an animal or human-derived blocking agent such as BSA or human serum albumin from plasma. These include:

• Occupational safety risks
• Regulatory requirements due to animal components
• Reagent IgG generating cross reactivity
• Inconsistent results
• Labeling guidelines for blood products

The Easy Solution

InVitria has designed diagnostic stabilizer reagents containing new recombinant albumin that specifically address these common problems.

Products from InVitria

Both Recombinant Albumin-DX and DX Lipid-Free:

• Consistently enhance the stability of assay biomarkers
• Improve antibody testing
• Chemically-defined diagnostic stabilizer reagents
• Make better blocking agents
• Produce better results
• Outperforming both BSA and human serum albumin from plasma

Eliminating animal and blood components in diagnostic stabilizer reagents is very beneficial:

• Using BSA and human serum albumin involves strict regulations and compliance with occupational safety.

• BSA is not an ideal or consistent blocking reagent. Sensitive techniques such as immunoassays or real-time PCR require consistency for precision.

How Invitria's Diagnostic Reagents Work

Recombinant Albumin-DX and DX Lipid-Free both contain a recombinant albumin produced in an animal component free production system.

It is highly purified, IgG-free and consistent, reducing non-specific binding and cross reactivity while maintaining the integrity of sensitive diagnostic biomarkers and proteins.

Recombinant Albumin DX boasts:

• High performance - outperforms BSA, and other animal- and blood-derived products commonly used as diagnostic stabilizer reagents

• Consistency - reproducible enhanced accuracy

• Regulatory-friendly - eliminates safety risks and meets regulatory guidelines while improving diagnostic outcomes

Sensitive assays and diagnostic biomarker kits need a consistent stabilizing reagent that performs well. InVitria's products exceed these diagnostic needs.

Click to purchase or learn more about Albumin-DX.

Click to purchase or learn more about Albumin-DX Lipid-Free.